Search results - 10 results
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
geographical classification. FINDINGS: We identified 5685 publications from database searches, of which 65 studies (comprising 44 769 men) were included from 35 countries. The global pooled prevalence was 31% (95% CI 27-35) for ...
The European response to the WHO call cervical cancer as a public health problem
(between 3 and 25/100000 women‐years) in 2018. HPV vaccine coverage is low in countries with the highest incidence and screening performance is heterogeneous among European countries. A broad group of ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
low in countries with the highest incidence and screening performance is heterogeneous among European countries. Cytological screening followed by treatment of screen-detected cervical lesions has ...
Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program.
Screening Papillomaviridae Papillomavirus Infections specimen handling Uterine Cervical Neoplasms Abstract: In 2016, the Netherlands will switch, as first European country, from cytology-based to HPV-based ...
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
burden of CC in the country so far. Changes with special focus on increasing coverage, development of information systems and assessment of quality are required to increase programme adherence to EuG and ...
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
countries are in the process of switching to high-risk human papillomavirus (hrHPV) testing for cervical cancer screening. Given the multitude of available tests, validated assays which assure high-quality ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
including a meta-regression to explore sources of heterogeneity. FINDINGS 148 studies were included, contributing data for 12 163 cases of head and neck squamous cell carcinoma from 44 countries. HPV DNA was ...
Screening for cervical cancer in Belgium" in Description of the national situation of cervical cancer screening in the member states of the European Union
European Union. There is yet high diversity in the status of cervical screening, and rapid changes expected to occur in the situation in many countries. It is important to underline differences in the health ...
The challenges of organising cervical screening programmes in the 15 old member states of the European Union.
was demonstrated in the Nordic countries, the United Kingdom, the Netherlands and parts of Italy. Opportunistic screening, often proposed at yearly schedules, has also reduced the burden of cervical ...
CanCon European Guide on Quality Improvement in Comprehensive Cancer Control- Chapter 4: Screening
here are currently lacking in many European settings, which may contribute substantially to inequalities in cancer prevention outcomes observed both between and within countries. Organization for the ...